v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Dec. 31, 2025
ASSETS:    
Cash $ 96,364 $ 115,645
Marketable securities 0 0
Non-marketable securities 3,161,359 3,161,359
Total Assets 3,257,723 3,277,004
LIABILITIES AND STOCKHOLDERS' EQUITY:    
Accounts payable and accrued expenses 57,087 58,732
Line of credit borrowings 348,843 348,843
Interest payable line of credit 83,356 69,850
Note payable and accrued interest 3,337,753 3,225,974
Total liabilities 3,826,939 3,703,399
Stockholders' equity    
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, $0.01 par value, 25,000,000 shares authorized, of which 3,472,491 shares are issued and outstanding as of December 31, 2022 and 2,937,225 at December 31, 2021 34,725 34,725
Additional paid-in capital 22,860,000 22,860,000
Additional paid-in capital - stock options 950,555 917,554
Accumulated deficit (25,654,852) (25,264,274)
Accumulated other comprehensive Income 1,762,930 1,548,174
Stockholders' Equity before Treasury Stock (46,642) 96,179
Less: Treasury Stock, 745,536 shares, at cost (522,574) (522,574)
Total stockholders' equity (569,216) (426,395)
Total liabilities and stockholders' equity $ 3,257,723 $ 3,277,004